MOTS-c
Mitochondrial Response
MOTS-c is a mitochondrial-derived peptide that acts as an endocrine signal to regulate metabolic homeostasis. Transcriptomics enables clinicians to monitor mitochondrial replication, AMPK pathway activation, and skeletal muscle glucose disposal in real time.
Tracked Physiological Dimensions
On the Advanced Transcriptomics Dashboard, MOTS-c response is tracked across two key bioenergetic dimensions.
Upregulating Mitochondrial Signaling
MOTS-c acts directly on the nucleus to regulate gene expression, targeting metabolic pathways. By promoting AMPK phosphorylation, MOTS-c upregulates glucose transporter (GLUT4) expression and fatty acid oxidation pathways (CPT1A).
By monitoring active transcripts, clinicians can trace metabolic adaptation and mitochondrial expansion. Quantifying changes in PGC-1α expression provides empirical proof of organelle biogenesis, verifying peptide-induced cellular restoration.
Key Target Genes
AMP-Activated Protein Kinase Energy Regulation
Upregulated by MOTS-c to stimulate fat oxidation and improve intracellular energy homeostasis.
Glucose Transporter Type 4 Glucose Transport
Drives insulin-independent glucose uptake into skeletal muscle, enhancing glycemic control.
PGC-1α Mitochondrial Biogenesis
Coordinates the transcription of mitochondrial DNA and respiration machinery.
Carnitine Palmitoyltransferase 1A Fatty Acid Oxidation
Enables mitochondrial uptake of long-chain fatty acids, accelerating lipid-burning rates.
Expected mRNA Expression Timeline
A typical timeline showing how active gene expression signals evolve during a MOTS-c therapy cycle.
AMPK & GLUT4 Mobilization
Upregulation of glucose transporters and energy regulatory enzymes indicating insulin sensitivity improvement.
Organelle Expansion
Peak expression of PGC-1α and mitochondrial lipid import enzymes (CPT1A) signals organelle biogenesis.
Metabolic Recalibration
Consolidated gains in metabolic adaptation scores and cellular energy efficiency indices.
Point-of-Care Mitochondrial Assays
Biomeme's platform offers rapid quantitative PCR tracking for mitochondrial and metabolism-regulating transcripts. Deliver clinical-grade metabolic profiling at the point of care in under 15 minutes, processed via CLIA-certified One Health Labs.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.